Related Experiment Video
Updated: Dec 13, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Alcohol use disorder and the liver.
Ryan Buchanan1, Julia M A Sinclair1
1Department of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Alcohol-related liver disease (ALD) is a major cause of death for those with alcohol use disorders (AUD). Integrated care is needed to manage AUD and ALD, as current treatments are limited.
Area of Science:
- Hepatology
- Addiction Medicine
- Public Health
Background:
- Alcohol use disorders (AUD) lead to significant physical harm, with alcohol-related liver disease (ALD) causing a substantial portion of alcohol-related mortality.
- ALD encompasses a spectrum of liver damage, from steatosis to cirrhosis, with no specific cure for cirrhosis itself.
- Hepatocellular carcinoma (HCC) and alcoholic hepatitis are severe complications of ALD, carrying high mortality rates.
Purpose of the Study:
- To highlight the critical link between alcohol use disorders and alcohol-related liver disease.
- To emphasize the progressive nature of ALD and its severe complications.
- To underscore the need for integrated care models for patients with comorbid AUD and ALD.
Main Methods:
- Review of existing literature on alcohol use disorders and alcohol-related liver disease.
- Analysis of the progression of liver pathology in ALD.
- Examination of current treatment limitations and intervention gaps.
Main Results:
- Alcohol consumption has an exponential relationship with ALD risk, influenced by genetics, lifestyle, and social factors.
- Abstinence is crucial for managing ALD progression, though cirrhosis and its complications like HCC and alcoholic hepatitis have limited treatment options.
- While effective interventions exist for AUD, few have been tested in patients with comorbid ALD.
Conclusions:
- Integrated specialist alcohol and hepatology services are essential for developing effective interventions and care pathways for patients with ALD and ongoing AUD.
- Addressing the complex interplay between AUD and ALD requires collaborative, multidisciplinary approaches.
- Further research is needed to adapt and trial existing AUD interventions for patients with liver disease.
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
CNS Depressants: Alcohol and Nicotine
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

